vimarsana.com

Page 3 - சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scientists find gene mutation linked to exfoliation syndrome,most common cause of glaucoma

 E-Mail IMAGE: Eye of a patient with exfoliation syndrome. The typical white exfoliation material deposits on the surface of the lens are visible (red arrows) with the aid of a slit lamp. view more  Credit: Agency for Science, Technology and Research (A STAR) s Genome Institute of Singapore,(GIS), Singapore Eye Research Institute (SERI) SINGAPORE - A team of researchers from the Agency for Science, Technology and Research s (A STAR) Genome Institute of Singapore (GIS) and Bioprocessing Technology Institute (BTI), as well as Singapore Eye Research Institute (SERI), have identified a genetic mutation (functionally defective CYP39A1 gene) associated with exfoliation syndrome, the most common cause of glaucoma. The findings could pave the way for future research on the cause of exfoliation syndrome and potential cures. Their research was published in Journal of the American Medical Association (JAMA) on 24 February 2021.

Johnson & Johnson Vision Announces Global Collaboration with Menicon to Bring Forward Contact Lenses to Help Manage the Progression of Myopia in Children

Johnson & Johnson Vision Announces Global Collaboration with Menicon to Bring Forward Contact Lenses to Help Manage the Progression of Myopia in Children - This new collaboration combines expertise from Menicon Co., Ltd., a world-class manufacturer of innovative contact lenses with the science, scale and capabilities of Johnson & Johnson Vision News provided by Share this article JACKSONVILLE, Fla., April 7, 2021 /PRNewswire/  Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced a global strategic collaboration with Menicon, a leading manufacturer of innovative contact lenses. The collaboration is part of a broader commitment from Johnson & Johnson Vision to lead with science and help reshape the future of myopia – and bring forward a novel portfolio of products and services to manage the progression of myopia in children.

J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration

tashatuvango -stock.adobe.com The collaboration comes on the heels of J&J winning approval from the Japanese Ministry of Health, Labour and Welfare for a contact lens that provides vision correction and an antihistamine drug to help relieve symptoms for people experiencing itchy allergy eyes. Johnson & Johnson Vision is teaming up with Menicon, a developer of contact lenses to address myopia or near-sightedness in children. The pact calls for Menicon to develop the contact lenses that would manage the progression of myopia. J&J Vision would focus on expanding the availability of the products across the world. “For decades, Johnson & Johnson Vision has invested in research collaborations with academic centers, research institutes and leading global health organizations who share our vision of leading with science to reshape the future of myopia and eye health,” said Peter Menziuso, Global President, Johnson & Johnson Vision Care. “Our collaborati

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.